POSTED BY KATRINA ANDERSON | 3 JULY 2024 Developing a regulatory regime for gene-edited food and what this means for industry The implementation of gene editing technology across different sectors is bringing rapid advances. Innovation in food and feed is an important application, with potential for addressing climate change and providing nutritional benefits. However, highly variable regulation presents difficulties for innovators. Read more Share this article Bookmark this page 4 min read
POSTED BY HUGH THOMPSON | 20 JUNE 2024 SPC protection for second medical uses ā hope on the horizon? In this blog, Hugh Thompson discusses the potential for the Court of Appeal to review existing law on SPCs which can extend patent protection for a pharmaceutical product in certain circumstances. Share this article Bookmark this page 3 min read
POSTED BY ISABEL TEARE | 13 JUNE 2024 Drafting for disaster ā a research project gone wrong Drafting life science research agreements requires care over limitations and exclusions of liability, as well as managing project progress, as a recent dispute demonstrates. Share this article Bookmark this page 4 min read
POSTED BY ISABEL TEARE | 31 MAY 2024 Developing consistent and transparent medtech evaluation NHS England and NICE are developing a more rigorous and transparent pathway for the evaluation of medtech innovations. Share this article Bookmark this page 2 min read
POSTED BY ISABEL TEARE | 28 MAY 2024 A testbed for medical device AI: the MHRAās AI Airlock The MHRA is establishing a regulatory sandbox for medical device AI to promote swift and effective regulation in this fast-moving field. Share this article Bookmark this page 2 min read
POSTED BY ISABEL TEARE | 17 MAY 2024 How to be clear about royalty payments in a pharmaceutical licensing transaction A recent Court of Appeal case looks at how to draft royalty clauses in a pharmaceutical patent licence, where claim scope and validity may be uncertain, and the product at an early stage of development. Share this article Bookmark this page 4 min read
POSTED BY HUGH THOMPSON | 10 MAY 2024 MHRA issues its first medicinal product approval through the International Recognition Procedure The MHRA has promised a pro-innovation agenda for life sciences. The first approval of a medicinal product through the International Recognition Procedure is a welcome step for industry and patients alike. Share this article Bookmark this page 2 min read
POSTED BY NICOLA HOLMES | 13 FEBRUARY 2024 Disparaging the competition? Recent competition law investigations in the life sciences sector highlight the need for caution when making statements about a competitor's products. Share this article Bookmark this page 3 min read
POSTED BY MARK PEARCE | 5 FEBRUARY 2024 Intellectual property issues around use of AI in life sciences AI is increasingly being used across many sectors, including life sciences. Intellectual property expert Mark Pearce considers some of the current issues, around both protection of innovations and use of data resources. Share this article Bookmark this page 4 min read
POSTED BY ISABEL TEARE | 1 FEBRUARY 2024 An update to the pharma industry's ABPI Code A review of the ABPI Code for the promotion of medicines in the UK is undergoing a review, with the changes expected to take effect before the end of 2024. Share this article Bookmark this page 2 min read
Subscribe Receive blog alerts via email from our leading team of legal experts Register Visitor Login